Table 1.
IC50 of IM with low concentrations of KPT-330 for K562G | ||
---|---|---|
Group | IC50 (μM) | IC50IM/IC50KPT-330 + IM |
IM | 5.099 | |
KPT-330(0.05 nM) + IM | 3.893 | 1.310 |
KPT-330(0.1 nM) + IM | 2.494 | 2.045 |
KPT-330(0.2 nM) + IM | 2.296 | 2.221 |
Low concentrations of KPT-330 were added with IM to enhance proliferation inhibition of K562G. IC50 of IM decreased as the concentrations of KPT-330 increased from 0.05 to 0.2 nM, which were nearly not toxic toward K562G. IC50 were calculated from MTS cytotoxic assay by SPSS 17.0 software. IC50 half maximal inhibitory concentration, IM Imatinib. Results were representative of 3 independent experiments